Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.6 USD | +1.42% | +13.68% | -22.60% |
15/04 | Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer | CI |
25/03 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
- Stock Market
- Equities
- NTLA Stock
- News Intellia Therapeutics, Inc.